FDA Safety Changes: Combivir, Hycamtin, Ultane

The FDA has approved revisions to the safety labeling for lamivudine-zidovudine (Combivir), topotecan (Hycamtin), and sevoflurane (Ultane). (CME,CE)Laurie Barclay

Continue to FDA Safety Changes: Combivir, Hycamtin, Ultane on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz